Skip to main content
. 2018 Jan;110(1):7–15. doi: 10.5935/abc.20170181

Figure 3.

Figure 3

Risk perception of stroke and bleeding by the patients before and after interacting with the application compared with the real risk, calculated by the CHA2DS2-VASc and HAS-BLED scores, showing a non-significant increase in the adequate perception of the risk. Comparisons were performed by the Wilcoxon test.